
    
      This is a phase 3, randomized, double-blind, placebo-controlled, multicenter, outpatient
      study to evaluate the efficacy and safety of larazotide acetate for the relief of persistent
      symptoms in adult patients with celiac disease on a gluten free diet.
    
  